WAGENHEIM PHILIP

Track

Insider profile

Performance

Overall performance
1.8
Performance over holding periods
1.8
30 days 90 days 120 days
Average return -17% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
WAGENHEIM PHILIP's trades of Immunome Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Immunome Inc (IMNM)
Transaction date
Sale
Price
114.17
Quantity 27,897 +9.9%
Value US$1,247,675
US Immunome Inc (IMNM)
Transaction date
Sale
Price
91.70
Quantity 24,041 +8.8%
Value US$3,244,690
US Immunome Inc (IMNM)
Transaction date
Proposed sale
Price
171.97
Quantity 69,139
Value US$2,062,880
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-23 2026-03-23
US Immunome Inc (IMNM)
S Sale
27,897 +9.9%
114.17
US$1,247,675 		27,897 +9.9% 114.17 US$1,247,675
2026-03-23 2026-03-20
US Immunome Inc (IMNM)
S Sale
24,041 +8.8%
91.70
US$3,244,690 		24,041 +8.8% 91.70 US$3,244,690
2026-03-20 2026-03-20
US Immunome Inc (IMNM)
PrS Proposed sale
69,139
171.97
US$2,062,880 		69,139 171.97 US$2,062,880